Movicol

Macrogol 3350, the active ingredient in Movicol, is an osmotic laxative presented as a powder for oral solution for oral use. It treats constipation and faecal impaction in adults and children as directed by a healthcare professional.

GNH USA supplies Movicol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Movicol, an osmotic laxative, is used to manage conditions affecting bowel motility and stool consistency. - Constipation: helps soften stool and promote regular bowel movements in patients with functional constipation. - Faecal impaction: facilitates evacuation of hardened stool in cases of fecal impaction. - Opioid‑induced constipation: aids in relieving constipation caused by opioid therapy when other measures are insufficient.

Movicol may cause a range of adverse reactions, most of which are related to its osmotic activity in the gastrointestinal tract.

Common Side Effects: - Abdominal bloating - Flatulence - Nausea - Diarrhea - Abdominal discomfort

Serious or Rare Side Effects: - Severe electrolyte imbalance (e.g., hyponatremia, hypokalemia) - Allergic reactions such as rash or angioedema - Severe abdominal pain - Dehydration - Rectal bleeding

When prescribing or using Movicol, several precautions should be considered to minimize risks and ensure safe use. - Assess renal function: evaluate kidney status before initiating therapy in patients with renal impairment. - Monitor electrolytes: regular checks are advised due to sodium and potassium content. - Use with caution in the elderly: increased susceptibility to dehydration and electrolyte shifts. - Avoid in bowel obstruction: the product may exacerbate obstruction. - Pregnancy and lactation: consult a healthcare professional before use. - Store at ambient temperature: keep in the original packaging, protect from moisture and heat.

Movicol can interact with other medicines, affecting electrolyte balance or gastrointestinal function.

Major Interactions (Avoid): - Concomitant use with other osmotic laxatives: may cause excessive fluid loss and electrolyte disturbances. - Loop diuretics: increased risk of hypokalemia and dehydration. - Mineral oil: may reduce the effectiveness of Movicol.

Moderate Interactions (Monitor Closely): - Antacids containing sodium: can add to sodium load, requiring electrolyte monitoring. - Potassium‑sparing diuretics: may lead to elevated potassium levels. - Lithium: potential for increased lithium concentrations.